Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Number of holders
-
71
-
Total 13F shares, excl. options
-
36.8M
-
Shares change
-
+1.68M
-
Total reported value, excl. options
-
$111M
-
Value change
-
+$5.32M
-
Put/Call ratio
-
0.66
-
Number of buys
-
43
-
Number of sells
-
-19
-
Price
-
$3.00
Significant Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) as of Q1 2024
90 filings reported holding GLYC - GLYCOMIMETICS INC - Common Stock, par value $0.001 per share as of Q1 2024.
GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) has 71 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.8M shares
.
Largest 10 shareholders include BVF INC/IL (9.54M shares), Artal Group S.A. (8.59M shares), NEA Management Company, LLC (3.84M shares), Octagon Capital Advisors LP (3M shares), VANGUARD GROUP INC (2.76M shares), AXA S.A. (1.59M shares), GOLDMAN SACHS GROUP INC (1.11M shares), MILLENNIUM MANAGEMENT LLC (747K shares), BlackRock Inc. (733K shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (555K shares).
This table shows the top 71 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.